The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
112783874 11278387 4 F 2011 20160711 20150717 20160801 EXP PHHY2015KR083317 NOVARTIS 0.00 F Y 52.00000 KG 20160801 CN COUNTRY NOT SPECIFIED KR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
112783874 11278387 1 PS TASIGNA NILOTINIB 1 Oral 400 MG, BID 22068 400 MG CAPSULE BID
112783874 11278387 2 SS TASIGNA NILOTINIB 1 Oral 800 MG, BID 22068 800 MG CAPSULE BID
112783874 11278387 3 SS TASIGNA NILOTINIB 1 Oral 600 MG, BID 22068 600 MG CAPSULE BID
112783874 11278387 4 SS TASIGNA NILOTINIB 1 Oral 300 MG, BID 22068 300 MG CAPSULE BID
112783874 11278387 5 SS GLIVEC IMATINIB MESYLATE 1 Oral 400 MG, QD 0 400 MG TABLET QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
112783874 11278387 1 Chronic myeloid leukaemia
112783874 11278387 5 Chronic myeloid leukaemia

Outcome of event

Event ID CASEID OUTC COD
112783874 11278387 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
112783874 11278387 Fatigue
112783874 11278387 Neoplasm malignant
112783874 11278387 Second primary malignancy
112783874 11278387 Weight decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
112783874 11278387 1 201011 201607 0
112783874 11278387 2 201011 201607 0
112783874 11278387 4 201607 0
112783874 11278387 5 20081031 0